Gemtuzumab ozogamicin |
Catalog No.GC64479 |
젬투주맙 오조가마신은 CD33을 대상으로 하는 단일 항체와 치료적인 Calicheamicin 유도체로 연결된 항체-약물 결합물(ADC)입니다. 젬투주맙 오조가마신은 급성 골수성 백혈병 연구에 사용될 수 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 220578-59-6
Sample solution is provided at 25 µL, 10mM.
Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) consisting of a monoclonal antibody targeting CD33 linked to a cytotoxic derivative of Calicheamicin. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia[1].
[1]. Baron J, et al. Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia. Expert Rev Clin Pharmacol. 2018;11(6):549-559.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *